Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × Escitalopram × Clear all

Phase

Status

Terminated 2 Unknown 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Depressive Disorder, Major 1 Breast Neoplasms 1

Interventions

Paclitaxel 3 Doxorubicin 3 Cyclophosphamide 3 Vincristine 2 Rituximab 2 Radiotherapy 2 Oxaliplatin 2 Methotrexate 2 Fluorouracil 2 Cytarabine 2 titanium silicide 1 sargramostim 1 pegaspargase 1 exemestane 1 eribulin 1 durvalumab 1 ceralasertib 1 Thioguanine 1 Taxes 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 S 1 (combination) 1 Prednisone 1 Prednisolone 1 Passive Cutaneous Anaphylaxis 1 Neoadjuvant Therapy 1 Morphine 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04973930 2025-05-13

IPT

New York State Psychiatric Institute

Phase 3 Suspended

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡